Covington advised lead investors Abingworth and other syndicate members on the round. Ascend closed its $130 million Series A fundraise. Ascend will use the proceeds to launch...
Ascend Gene & Cell Therapies’ $130 Million Series A Fundraise
Oxford Biomedica’s £80 Million Placing
Travers Smith advised Peel Hunt and WG Partners on the deal. Peel Hunt and WG Partners acted as joint bookrunners, on the £80m placing by Oxford...
The Serum Institute of India’s £50 Million Investment in Oxford Biomedica
Covington & Burling advised Oxford Biomedica on the deal. The Serum Institute of India, the world’s largest vaccine maker, has agreed, via its subsidiary Serum Life...